Delivery Order SPE2DB22D1041-SPE2DB25FUAZ2
Award Date
7/2/25
Potential Completion Date
7/3/25
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of LOTEPREDNOL ETABONATE 0.5% DRP 5ML medication. The $1,147.30 firm fixed price award was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of June 12, 2025. The contract is not set aside and represents a delivery order under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,097.35, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of LOTEPREDNOL ETABONATE 0.2% DRP 5ML, a pharmaceutical eye drop product. The contract has an ultimate completion date of December 24, 2024 and is a firm fixed-price contract. AmerisourceBergen, a for-profit organization, is the prime contractor,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,261.14 firm-fixed-price delivery order is for the supply of LOTEPREDNOL ETABONATE 0.5% DRP 5ML, a prescription medication. The contract has an ultimate completion date of June 5, 2025 and was awarded on June 4, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a for-profit organization headquartered in...
This is a $3,964.93 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of LOTEPREDNOL ETABONATE 0.5% DRP 10ML, a pharmaceutical product. The contract has an ultimate completion date of June 11, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of LOTEPREDNOL ETABONATE 0.2% DRP 5ML, a pharmaceutical product, with a ceiling value of $5,394.32. The contract has an ultimate completion date of April 10, 2025 and was awarded on April 9, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,672.09, is for the delivery of Loteprednol Etabonate 0.5% eye drops. The contract is a firm fixed-price delivery order with a completion date of December 19, 2022. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,102.82 firm fixed-price delivery order is for the supply of Loteprednol Etabonate 0.5% ophthalmic drops (5ml). The contract was awarded on September 7, 2021, with a completion date of September 8, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc. and is registered in the System...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of loteprednol 0.5% ophthalmic gel, a prescription pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,645.18 and a completion date of July 15, 2024. The contract is a delivery order placed against Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025. This...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $1,240.45 firm fixed-price contract is for the delivery of Loteprednol Etabonate 0.5% ophthalmic drops. The order has a completion date of June 23, 2025 and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of loteprednol etabonate 0.5% eye drops, in 5 ml quantities, to the Defense Logistics Agency (DLA). The $2,143.44 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on March 1, 2023, with an ultimate completion date of March 2, 2023. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite Delivery...